You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

ACHROMYCIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Achromycin, and what generic alternatives are available?

Achromycin is a drug marketed by Lederle, Storz, and Avet. and is included in seven NDAs.

The generic ingredient in ACHROMYCIN is hydrocortisone; tetracycline hydrochloride. There are sixty-seven drug master file entries for this compound. Additional details are available on the hydrocortisone; tetracycline hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACHROMYCIN?
  • What are the global sales for ACHROMYCIN?
  • What is Average Wholesale Price for ACHROMYCIN?
Summary for ACHROMYCIN
US Patents:0
Applicants:3
NDAs:7
Raw Ingredient (Bulk) Api Vendors: 67
DailyMed Link:ACHROMYCIN at DailyMed
Drug patent expirations by year for ACHROMYCIN

US Patents and Regulatory Information for ACHROMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle ACHROMYCIN procaine hydrochloride; tetracycline hydrochloride INJECTABLE;INJECTION 050276-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Storz ACHROMYCIN tetracycline hydrochloride SUSPENSION/DROPS;OPHTHALMIC 050268-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lederle ACHROMYCIN tetracycline hydrochloride INJECTABLE;INJECTION 050273-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Avet ACHROMYCIN V tetracycline hydrochloride CAPSULE;ORAL 050278-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lederle ACHROMYCIN procaine hydrochloride; tetracycline hydrochloride INJECTABLE;INJECTION 050276-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.